Parathyroid Carcinoma: a Review
- PMID: 35462650
- PMCID: PMC8986943
- DOI: 10.1007/s13193-021-01343-3
Parathyroid Carcinoma: a Review
Abstract
Parathyroid cancer is a rare endocrine malignancy with only a few thousand cases reported worldwide. As a result, there exists considerable controversy regarding the various aspects of this disease, viz., etiology, diagnosis, and management. We hereby attempt to review the literature on parathyroid carcinoma (PC) and summarize the practices based on the current evidence available. The majority of the PC are sporadic although an association with hyperparathyroidism-jaw tumor syndrome, multiple endocrine neoplasia (MEN) 1 and 2, and isolated familial hyperparathyroidism has been shown. As preoperative diagnosis is challenging, PC should be suspected in patients presenting with a neck mass with signs and symptoms of invasion to surrounding structures. Skeletal and renal symptoms are often associated with PC as presenting complaints. The biochemical parameters are more pronounced in the case of PC compared with benign countpart. Due to its rarity, the American Joint Committee of cancer control (AJCC) acknowledges that as yet a clear distinct staging system to prognosticate the disease would be premature. Complete excision with negative margins at first surgery offers the best chance of cure. The role of radiotherapy (RT) is still unclear; however few series have suggested a better locoregional control with adjuvant RT. Recurrences are common and are most significantly associated with an incomplete clearance at initial surgery. Surgical salvage of recurrent/metastatic disease with medical management of hypercalcemia is the treatment of choice. Large prospective studies and trials need to be conducted to understand the pathology better and improve management protocols; however this is a challenge due to rarity of cases.
Keywords: Endocrine cancers; Hypercalcemia; Parathyroid neoplasms; Parathyroid neoplasms/ diagnosis; Parathyroid neoplasms/ surgery.
© Indian Association of Surgical Oncology 2021.
Conflict of interest statement
Conflict of InterestNo conflict of interest.
Figures



References
-
- Lee PK, Jarosek SL, Virnig BA, Evasovich M, Tuttle TM. Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer. 2007;109:1736–1741. - PubMed
-
- Hakaim AG, Esselstyn CB., Jr Parathyroid carcinoma: 50-year experience at the Cleveland Clinic Foundation. Cleve Clin J Med. 1993;60:331–335. - PubMed
-
- De Quervain F. Parastruma maligna aberrata [in German] Deutsche Zeitschrift fur Chirurgie. 1909;100:334–353.
-
- Kebebew E. Parathyroid carcinoma. Curr Treat Options in Oncol. 2001;2(4):347–354. - PubMed
Publication types
LinkOut - more resources
Full Text Sources